Pediatric Rheumatology Online Journal (Sep 2008)

12.4 ACZ885 (canakinumab), a new IL-1 beta blocking monoclonal antibody provides long-lasting remission in children with cryopyrin associated periodic syndrome (CAPS)

  • Kümmerle-Deschner J,
  • Blank N,
  • Roesler J,
  • Ramos E,
  • Tzaribachev N,
  • Gramlich K,
  • Well C,
  • Felix SD,
  • Rordorf C,
  • Jung T

DOI
https://doi.org/10.1186/1546-0096-6-S1-S26
Journal volume & issue
Vol. 6, no. Suppl 1
p. S26

Abstract

Read online

No abstracts available.